Why is Episurf Medical AB ?
1
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -69.90%, its profits have risen by 22.9%
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -69.90% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Episurf Medical AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Episurf Medical AB
-100.0%
-1.01
87.63%
OMX Stockholm 30
8.45%
0.44
18.11%
Quality key factors
Factor
Value
Sales Growth (5y)
22.47%
EBIT Growth (5y)
1.14%
EBIT to Interest (avg)
-78.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.15
Tax Ratio
0.56%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.11
EV to EBIT
-0.60
EV to EBITDA
-0.69
EV to Capital Employed
1.15
EV to Sales
3.06
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-190.98%
ROE (Latest)
-138.26%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
6What is working for the Company
OPERATING CASH FLOW(Y)
Highest at SEK -59.8 MM
NET PROFIT(HY)
Higher at SEK -34.3 MM
RAW MATERIAL COST(Y)
Fallen by -23.97% (YoY
-5What is not working for the Company
CASH AND EQV(HY)
Lowest at SEK 48.4 MM
DEBT-EQUITY RATIO
(HY)
Highest at -20.04 %
NET SALES(Q)
Lowest at SEK 2.9 MM
Here's what is working for Episurf Medical AB
Net Profit
Higher at SEK -34.3 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (SEK MM)
Operating Cash Flow
Highest at SEK -59.8 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (SEK MM)
Raw Material Cost
Fallen by -23.97% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Episurf Medical AB
Net Sales
At SEK 2.9 MM has Fallen at -17.14%
over average net sales of the previous four periods of SEK 3.5 MMMOJO Watch
Near term sales trend is very negative
Net Sales (SEK MM)
Net Sales
Lowest at SEK 2.9 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (SEK MM)
Cash and Eqv
Lowest at SEK 48.4 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -20.04 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio






